Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imanova
London, United Kingdom
- Ownership
- Private
- Employees
- ~90
- Development stage
- Other
01
Overview
Imanova develops and applies PET and MRI imaging biomarkers (including proprietary 11C and 18F tracers) to support early‑stage and translational drug development, with its radiotracers in preclinical and early clinical evaluation but no therapeutic products on the market.[1][2][3][6][7]
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- RadiopharmaceuticalSmall molecule
- Industry
- Medical Imaging
02
Partnerships
TevaUniversity College LondonImperial College LondonKing’s College LondonMedical Research Council (UK)Mitsubishi Tanabe Pharma
Beyond the preview
Go deeper on Imanova.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Imanova.